A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
A Study to Compare the Taste and Levels in Blood Plasma of BMS-986165 When Taken as Different Formulations by Healthy Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Advanced Solid Tumors and Hematological Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Study to Evaluate the Effect of Rifampin on the Drug Levels in Blood and Safety of BMS-986235 in Healthy Participants
- Status
- WITHDRAWN
- Phase
- PHASE1
Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
CIML NK Cell in Head & Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Tumor Mutational Burden in Lung Cancer Patients
- Status
- TERMINATED
- Phase
- N/A
Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX)
- Status
- COMPLETED
- Phase
- PHASE2
A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Intratumoral Microdosing of Motolimod in HNSCC
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986256 in Healthy Male Participants
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH)
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Examine the Acceptable Taste and to Estimate the Amount of Atazanavir and Cobicistat in the Body When Taken as a Combination Product Versus When Taken as Separate Products at the Same Time
- Status
- COMPLETED
- Phase
- PHASE1
Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line Treatment
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluation of UCPVax Plus Nivolumab as Second Line Therapy in Advanced Non Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
COL Immunotherapy Before Radiochimio + Ipilimumab
- Status
- COMPLETED
- Phase
- NA
A Study of NIVO Plus IPI and Guadecitabine or NIVO Plus IPI in Melanoma and NSCLC Resistant to Anti-PD1/PDL1
- Status
- UNKNOWN
- Phase
- PHASE2
Pharmacokinetics (Drug Levels in Blood) of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Pharmacokinetics (Drug Levels and Metabolism), Safety, and Tolerability of BMS-986259 in Participants With Various Levels of Kidney Function
- Status
- COMPLETED
- Phase
- PHASE1